Serum Neurofilament Light Chain Levels in Parkinson’s Disease Therapy: Preliminary Results from a Phase 2 Clinical Trial of Allogenic Bone Marrow-derived Mesenchymal Stem Cell

Ethnoracial Disparities in Grey Matter Atrophy in Multiple Sclerosis Are Mediated by Structural Disconnectivity

Socioeconomic Status and Its Impact on Clinical and Radiographic Findings in MOGAD at Diagnosis

Motivations and Burdens of Participation in Parkinson’s Disease Clinical Trials: Experiences from a Disease-modifying Phase 2 Study